Archive
Year
Volume(Issue)
Issues
Journal Article
Download
فارسی Version
Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Year:
Volume:
Issue:
Pages:
Citations:
Views:
Downloads:
more
View 31
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
View 67
Recent Progress in understanding 2019 novel coronavirus associated with human respiratory disease: detection, mechanism and treatment
View 40
Coronavirus disease 2019 (COVID-19): current status and future perspectives
View 59
The epidemiology, diagnosis and treatment of COVID-19
View 84